PM

Peter Maag

North America, California, United States

Description

Peter Maag is the current Chief Executive Officer of Kyverna Therapeutics. He previously worked at CareDx as a Chairman of the Board and Chi...

Investor Profile

Peter Maag has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Debt Financing (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Peter Maag frequently co-invest with?

Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Peter Maag?

Bridge to Life Ltd.

Northbrook, Illinois, United States

Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.

Biotechnology
Debt FinancingAug 19, 2021
Bridge to Life Ltd.

Northbrook, Illinois, United States

Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.

Biotechnology
Series AAug 19, 2021
Amount Raised: $56,000,000